U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Midazolam Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 04/02/2020
»Therapeutic Categories: Anesthesia; Neurology

Expand all

Avet Pharmaceuticals, Inc. (Reverified 07/01/2026)

Company Contact Information:
855-228-9470

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) Unavailable Manufacturing delay. Estimated availability: 7/30/2026 Other
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) Available
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) Limited Availability Estimated recovery: TBD Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 06/17/2026)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) Unavailable Estimated recovery: TBD Delay in shipping of the drug
Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) Unavailable Estimated recovery: TBD Demand increase for the drug
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) Unavailable Next release July 2026. Check wholesalers for inventory. Demand increase for the drug
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) Unavailable Next release July 2026. Check wholesalers for inventory. Demand increase for the drug
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) Available Check wholesalers for inventory
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) Unavailable Estimated recovery: TBD Demand increase for the drug
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) Available Check wholesalers for inventory

Gland Pharma Limited (Reverified 06/12/2026)

Company Contact Information:
Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) Unavailable Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals Other
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) Unavailable Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals Other

Hikma Pharmaceuticals USA, Inc. (Reverified 07/13/2026)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Hospira, Inc., a Pfizer Company (Reverified 07/10/2026)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) Available
Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) Limited Availability Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay Other
Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) Limited Availability Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026 Demand increase for the drug
Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) Available
Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) Limited Availability Limited Supply Available. Next Delivery: July 2026; Estimated Recovery: September 2026 Demand increase for the drug
Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) Available
Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) Available

WG Critical Care (Reverified 07/01/2026)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) Available Please check wholesalers and distributors for inventory.
Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) Available Please check wholesalers and distributors for inventory.
Back to Top